Used to evaluate genetic exposure to toxic carcinogenic or mutagenic agents [42]An example includes PI3K pathway mutation assessment for head and neck squamous cell carcinoma and γ-H2AX formation for prediction, prognosis, diagnosis and treatment response in different human cancer cell lines, premalignant lesions and solid tumors [52–54]. Here, H2AX is linked to cancer.